Q32 Bio Inc. (QTTB)

Q32 Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	106.27	48.3	77.97	25.62	43.89	32.25
Cash & Short-Term Investments	106.27	48.3	77.97	25.62	43.89	32.25
Cash Growth	93.81%	-38.05%	204.35%	-41.64%	36.12%	-
Other Receivables	0.56	0.56	0.56	0.76	1.06	0.91
Receivables	0.56	0.56	0.56	0.76	1.06	0.91
Prepaid Expenses	0.88	1.34	2.96	2.26	1.75	0.77
Other Current Assets	1.95	4.86	0.4	0.08	0.15	0.07
Total Current Assets	109.65	55.05	81.88	28.72	46.85	34
Property, Plant & Equipment	5.57	6.08	7.09	8.08	9.17	0.2
Long-Term Investments	-	-	2.6	-	-	-
Other Long-Term Assets	0.65	0.65	0.76	10.26	5.76	0.95
Total Assets	115.87	61.78	92.33	47.06	61.77	35.15

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.57	0.88	2.99	3.47	1.44	2.68
Accrued Expenses	3.1	3.54	6.87	8.91	8.46	4.54
Current Portion of Long-Term Debt	-	6.24	3.1	0.88	32.4	-
Current Portion of Leases	0.74	0.69	0.61	0.54	0.47	-
Current Income Taxes Payable	-	-	-	0.32	0.57	-
Current Unearned Revenue	-	-	-	-	14.53	-
Other Current Liabilities	-	-	2.9	-	-	-
Total Current Liabilities	5.4	11.35	16.47	14.11	57.87	7.22
Long-Term Debt	-	3.47	9.56	43.18	5.07	4.97
Long-Term Leases	4.56	4.94	5.64	6.25	6.79	-
Long-Term Unearned Revenue	-	-	-	-	11.32	-
Other Long-Term Liabilities	-	-	55	55	-	0.73
Total Liabilities	9.96	19.76	86.66	118.53	81.04	12.92

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	327.45	247.01	240.49	4.16	2.63	1.32
Retained Earnings	-221.55	-204.99	-234.81	-187.08	-133.34	-90.53
Total Common Equity	105.91	42.01	5.68	-182.92	-130.71	-89.21
Shareholders' Equity	105.91	42.01	5.68	-71.48	-19.27	22.24
Total Liabilities & Equity	115.87	61.78	92.33	47.06	61.77	35.15

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	5.3	15.34	18.9	50.84	44.73	4.97
Net Cash (Debt)	100.97	32.95	59.06	-25.22	-0.84	27.28
Net Cash Growth	179.44%	-44.21%	-	-	-	-
Net Cash Per Share	6.80	2.68	6.12	-72.26	-0.12	4.21
Filing Date Shares Outstanding	29.77	14.63	12.2	11.93	7.14	6.47
Total Common Shares Outstanding	23.74	12.86	12.2	7.47	7.14	6.47
Working Capital	104.25	43.7	65.41	14.61	-11.01	26.78
Book Value Per Share	4.46	3.27	0.47	-24.48	-18.31	-13.79
Tangible Book Value	105.91	42.01	5.68	-182.92	-130.71	-89.21
Tangible Book Value Per Share	4.46	3.27	0.47	-24.48	-18.31	-13.79
Machinery	1.82	1.82	1.82	1.81	1.81	0.31
Leasehold Improvements	1	1	1	0.94	0.94	-

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error